IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

March Altus Capital Management LP

Q2 2015 Holdings

Filed 2015-08-14 | 20 holdings | $350.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Catalyst Pharmaceuticals Inc(CPRX)COM14888U101$334.0K80,89095.2%
Universal Hlth Svcs Inc(UHS)CL B913903100$2.1K14,6630.6%
United Therapeutics Corp del(UTHR)COM91307C102$1.7K10,0090.5%
Lilly ELI & Co(LLY)COM532457108$1.3K15,7380.4%
Dexcom Inc(DXCM)COM252131107$1.2K15,5040.4%
Regeneron Pharmaceuticals(REGN)COM75886F107$1.2K2,2940.3%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$1.1K5,9490.3%
Thoratec CorpCOM NEW885175307$1.0K23,4860.3%
Cynosure IncCL A232577205$98325,4750.3%
Mallinckrodt PUB LTD CoSHSG5785G107$9638,1770.3%
Cigna CorporationCOM125509109$7844,8420.2%
Humana Inc(HUM)COM444859102$7393,8620.2%
Zoetis Inc(ZTS)CL A98978V103$72114,9560.2%
Amerisourcebergen Corp(COR)COM03073E105$7136,7070.2%
Zeltiq Aesthetics IncCOM98933Q108$53518,1650.2%
Receptos IncCOM756207106$4282,2510.1%
Seattle Genetics IncCOM812578102$4248,7680.1%
Neurocrine Biosciences Inc(NBIX)COM64125C109$4108,5930.1%
Ultragenyx Pharmaceutical in(RARE)COM90400D108$3383,2990.1%
Agenus Inc(AGENEUR)COM NEW00847G705$16018,5170.0%